ARS Pharmaceuticals Ownership | Who Owns ARS Pharmaceuticals?
ARS Pharmaceuticals Ownership Summary
ARS Pharmaceuticals is owned by 91.75% institutional investors, 16.18% insiders. Ra capital management is the largest institutional shareholder, holding 10.94% of SPRY shares. American Funds SMALLCAP World A is the top mutual fund, with 2.70% of its assets in ARS Pharmaceuticals shares.
SPRY Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | ARS Pharmaceuticals | 91.75% | 16.18% | -7.94% |
| Sector | Healthcare Stocks | 50.59% | 12.40% | 37.01% |
| Industry | Biotech Stocks | 49.10% | 12.14% | 38.76% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Ra capital management | 10.86M | 10.94% | $87.00M |
| Rubric capital management lp | 8.54M | 8.60% | $68.41M |
| Orbimed advisors | 8.29M | 8.35% | $66.39M |
| Deerfield management company, l.p. (series c) | 7.50M | 7.56% | $60.11M |
| Blackrock funding, inc. /de | 5.31M | 5.35% | $42.54M |
| Tyro capital management | 4.46M | 4.49% | $35.72M |
| Abrdn | 4.17M | 4.20% | $33.41M |
| Sr one capital management, lp | 4.01M | 4.04% | $32.14M |
| State street | 3.73M | 3.76% | $29.88M |
| Vanguard group | 3.51M | 3.55% | $40.88M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Tyro capital management | 4.46M | 8.01% | $35.72M |
| Sr one capital management, lp | 4.01M | 3.09% | $32.14M |
| Bioimpact capital | 1.30M | 2.14% | $13.10M |
| Tejara capital | 607.04K | 2.00% | $4.86M |
| Nextech invest | 936.73K | 1.60% | $9.88M |
| Orbimed advisors | 8.29M | 1.24% | $66.39M |
| Ra capital management | 10.86M | 0.76% | $87.00M |
| Rubric capital management lp | 8.54M | 0.63% | $68.41M |
| Deerfield management company, l.p. (series c) | 7.50M | 0.63% | $60.11M |
| Investment management associates inc /adv | 373.49K | 0.61% | $2.99M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Capital world investors | 2.75M | 0.00% | 2.75M |
| Tyro capital management | 4.46M | 8.01% | 1.49M |
| Boothbay fund management | 1.60M | 0.17% | 1.35M |
| Qube research | 1.03M | 0.01% | 1.03M |
| Peregrine capital management | 672.14K | 0.17% | 672.14K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Millennium management | 2.40M | 0.01% | -3.58M |
| Franklin resources | - | - | -3.28M |
| Adage capital partners gp | - | - | -1.73M |
| Casdin capital | - | - | -1.60M |
| Southpoint capital advisors lp | - | - | -1.50M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Capital world investors | 2.75M | 0.00% | 2.75M | $22.07M |
| Qube research | 1.03M | 0.01% | 1.03M | $10.40M |
| Peregrine capital management | 672.14K | 0.17% | 672.14K | $5.38M |
| Sixth street partners management company | 551.42K | 0.00% | 551.42K | $4.42M |
| Jump financial | 255.20K | 0.02% | 255.20K | $2.04M |
Sold Out
| Holder | Change |
|---|---|
| National bank of canada /fi/ | -1.00 |
| Freestone grove partners lp | -2.00 |
| Mai capital management | -5.00 |
| Principal securities | -17.00 |
| Pinnacle wealth planning services | -17.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | 212 | 2.42% | 91,106,084 | -3.19% | 91 | 1.02% | 115 | 12.75% | 52 | -8.77% |
| Mar 31, 2026 | 128 | -34.36% | 35,806,185 | -59.76% | 36 | 0.45% | 62 | -32.61% | 35 | -40.68% |
| Dec 31, 2025 | 144 | -28.00% | 49,264,084 | -41.09% | 49 | 0.69% | 69 | -39.47% | 42 | -10.64% |
| Sep 30, 2025 | 196 | 1.03% | 83,443,647 | -1.27% | 84 | 1.15% | 111 | -1.77% | 46 | - |
| Jun 30, 2025 | 192 | 1.59% | 84,508,656 | 10.87% | 85 | 1.42% | 111 | 12.12% | 46 | -16.36% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| American Funds SMALLCAP World A | 2.68M | 2.70% | 2.68M |
| State Street® SPDR® S&P® Biotech ETF | 2.25M | 2.27% | 5.17K |
| Vanguard US Total Market Shares ETF | 1.86M | 1.90% | - |
| Vanguard Morn Total Stk Mkt Idx Investor | 1.75M | 1.76% | - |
| Vanguard Total Stock Mkt Idx Inv | 1.75M | 1.76% | - |
| Vanguard MStar Total Stk Mkt Idx Invest | 1.75M | 1.76% | - |
| abrdn Healthcare Investors | 1.57M | 1.59% | - |
| iShares Russell 2000 ETF | 1.57M | 1.58% | -27.94K |
| Franklin Biotechnology Discv A(acc)USD | 1.56M | 1.57% | - |
| abrdn Healthcare Opportunities | 1.30M | 1.31% | -505.27K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jun 12, 2026 | Karas Eric | Chief Commercial Officer | Sell | $250.00K |
| Jun 12, 2026 | Fitzpatrick Alexander A | Chief Legal Officer | Sell | $33.55K |
| Nov 13, 2025 | Dorsey Brian | Chief Operating Officer | Sell | $190.05K |
| Nov 12, 2025 | Chakma Justin | Chief Business Officer | Sell | $267.36K |
| Nov 12, 2025 | Chakma Justin | Chief Business Officer | Sell | $1.21M |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q3 | - | - |
| 2026 Q2 | - | 2 |
| 2026 Q1 | - | - |
| 2025 Q4 | - | 3 |
| 2025 Q3 | - | 5 |
SPRY Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools